Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy According to Hedge Funds. On March 21, ...

Nifty Pharma index rises 3% led by Sun Pharma, Gland Pharma and Zydus Lifesciences; Dr Reddy's gains on potential semaglutide ...

Shares of Dr Reddy's Laboratories surged sharply on Thursday, bucking a weak broader market and emerging as one of the top ...

After its third quarter results, the management of Dr. Reddy's Laboratories had said that they expect to hear on the ...

Dr. Reddy's Laboratories jumps 7% as NIFTY Pharma rises 2.33%. Explore key reasons behind the rally, including rupee weakness, export gains, and defensive sector rotation.

Glenmark Pharma, Cipla, Wockhardt, Mankind Pharma, Lupin, Zydus Life, Laurus, Ipca Labs, Divis Labs, Strides Pharma and ...

Join us on the Dr Reddys Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay ...

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Dr Reddy’s Laboratories has received the Drug Identification Numbers (DINs) for Semaglutide Injection from Health Canada as ...

Dr. Reddy's Laboratories Ltd. closed 11.68% below its 52-week high of 1,377.95 rupees, which the company achieved on June 12th.

Dr Reddy's Laboratories reported a 36 per cent increase in its consolidated profit after tax at Rs 1,307 crore for the ...

Dr. Reddy's Laboratories Ltd. closed 11.41% below its 52-week high of 1,377.95 rupees, which the company achieved on June 12th.